(Q44796643)

6 December 2017

title

Risk assessment, prediction and prevention of type 1 diabetes (English)

1 reference

6 December 2017

0 references

Harrison LC

1

1 reference

6 December 2017

publication date

1 June 2001

1 reference

6 December 2017

1 reference

6 December 2017

volume

2

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

71-82

1 reference

Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

HIGH FREQUENCY OF DIABETES MELLITUS IN YOUNG ADULTS WITH CONGENITAL RUBELLA

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

Antigen-specific therapy for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

A novel micro-assay for insulin autoantibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAB Workshop.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Comparison of two commonly used standard IVGTTs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Standardization of IVGTT to predict IDDM

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Reproducibility of the First-Phase Insulin Response to Intravenous Glucose Is Not Improved by Retrograde Cannulation and Arterialization or the Use of a Lower Glucose Dose

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Can islet cell antibodies predict IDDM in the general population?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Islet cell antibodies in normal French schoolchildren

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Neural network-based prediction of candidate T-cell epitopes.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Costs of predicting IDDM

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Psychological impact of islet cell-antibody screening. Preliminary results.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Lack of association between duration of breast-feeding or introduction of cow's milk and development of islet autoimmunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Oral tolerance: mechanisms and therapeutic applications.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Intranasal administration of insulin peptide B: 9-23 protects NOD mice from diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Suppression of the immune response by nasal immunization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Nicotinamide: potential for the prevention of type 1 diabetes?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

Costs of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2001.002002071.X

7 January 2021

10.1034/J.1399-5448.2001.002002071.X

Identifiers

DOI

1 reference

release_6luxafimbzcd3ebircimv3qnbq

6 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6luxafimbzcd3ebircimv3qnbq

24 November 2022

mapped directly with Wikidata item

1 reference